In addition to leading-edge research currently funded by the Scleroderma Society of Ontario, the following current studies, lead by prominent scientific and medical experts, describe exciting new research in the area of scleroderma.

Scleroderma:  A Program to Study Outcomes and Experiences Important to Patients

-Thombs, B. (Principal Investigator)

Improved Diagnositic Criteria for Systemic Sclerosis

-Pope, J. E. (Principal Investigator)

The Genome-Wide Association Scan Study in Systemic Sclerosis

-Mayes, M.(Principal Investigator)

Development and Validation of a Patient-Assessed Disease Activity Index in Systemic Sclerosis

-Hudson, M.(Principal Investigator)

Oral Health Study

-Gornitsky, M. (Principal Investigator)

Treatment With Rapamycin Prevents Fibrosis in Tight-Skin and Bleomycin-Induced Mouse Models of Systemic Sclerosis

-Yoshizaki, A. (Principal Investigator)